Research Agenda
Sign up for the IfHI Newsletter
|
Ongoing research under IfHI sponsorship is currently investigating the effect of ABO blood groups and soluable endothelial adhesion factors and a possible cause of atherogenesis.
The IfHI
research faculty is currently developing study protocols to evaluate
the following questions.
- What
is the role of lectins and immuno-therapeutics in sample
patient population previously vaccinated with smallpox?
- What
are cost-effective and practical methods of evaluating effects
of lectins and immuno-therapeutics?
- What
is the role of lectin manipulation and chronic inflammatory
conditions?
- Are
the differences in soluble cell adhesion molecule levels known
to influenced by diet predictable by ABO and secretor genotype?
- What
symptoms specific questionnaire can reliably and consistently
measure the effects of dietary lectins?
- Can
circulating levels of anti-Thomsen Friedenreich antibodies be
enhanced by diet?
- Are
difference in blood coagulation predictable by ABO genotype a
reliable indicator of effective stress management?
- What
are the effects of dietary lectins on serum insulin levels?
- What
are the effects of ABO polymorphism and secretor genotype on
hepatitis C progression?
- What
is the clinical relevance of known botanical mediators of ICAM
expression on the management of diabetes in individuals of
varying ABO blood groups?
- What
are the predictive linkage relationships and lectin reactivities
in colonic metaplasia?
- What
are the effects of targeted probiotic therapy as per ABO and
secretor genotypes?
- What
symptoms specific questionnaire can reliably and consistently
measure the effect of treating disease conditions with dietary
lectins?
- What
clinical outcomes adequately evaluates efficacy/treatment
response of dietary lectins in chronic diseases?
- What
is the correlation of genetic polymorphism, lectins, disease
condition/manifestation, and treatment outcome?
- What
is the most effective treatment protocol applying the principles
of human individuality and dietary lectins?
- What
is the role of addressing human individuality and
complementary/alternative medicine therapies?
| |
